<HashMap><database>biostudies-literature</database><scores/><additional><submitter>VanderWalde N</submitter><funding>National Cancer Institute</funding><funding>NCI NIH HHS</funding><pagination>294-301</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8967782</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Expected toxicity from chemoradiation (CRT) is an important factor in treatment decisions but is poorly understood in older adults with lower gastrointestinal (GI) malignancies. Our objective was to compare acute adverse events (AAEs) of older and younger adults with lower GI malignancies treated on NRG studies.&lt;h4>Methods&lt;/h4>Data from 6 NRG trials, testing combined modality therapy in patients with anal or rectal cancer, were used to test the hypothesis that older age was associated with increased AAEs. AAEs and compliance with protocol-directed therapy were compared between patients aged ≥70 and &lt; 70. Categorical variables were compared across age groups using the chi-square test. The association of age on AAEs was evaluated using a covariate-adjusted logistic regression</pubmed_abstract><journal>Journal of geriatric oncology</journal><pubmed_title>The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.</pubmed_title><pmcid>PMC8967782</pmcid><funding_grant_id>UG1 CA189867</funding_grant_id><funding_grant_id>UG1 CA233290</funding_grant_id><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>U10 CA180868</funding_grant_id><funding_grant_id>U10 CA180822</funding_grant_id><pubmed_authors>Lichtman SM</pubmed_authors><pubmed_authors>Berger A</pubmed_authors><pubmed_authors>Arora A</pubmed_authors><pubmed_authors>Lee RJ</pubmed_authors><pubmed_authors>VanderWalde A</pubmed_authors><pubmed_authors>Ellsworth SG</pubmed_authors><pubmed_authors>Kachnic L</pubmed_authors><pubmed_authors>Meyer J</pubmed_authors><pubmed_authors>Crane CH</pubmed_authors><pubmed_authors>Jagsi R</pubmed_authors><pubmed_authors>VanderWalde N</pubmed_authors><pubmed_authors>Moughan J</pubmed_authors><pubmed_authors>Green N</pubmed_authors><pubmed_authors>Hopkins JL</pubmed_authors><pubmed_authors>Meropol NJ</pubmed_authors><pubmed_authors>Anne R</pubmed_authors><pubmed_authors>Ballo M</pubmed_authors><pubmed_authors>Ajani J</pubmed_authors><pubmed_authors>Mohiuddin M</pubmed_authors></additional><is_claimable>false</is_claimable><name>The association of age with acute toxicities in NRG oncology combined modality lower GI cancer trials.</name><description>&lt;h4>Purpose&lt;/h4>Expected toxicity from chemoradiation (CRT) is an important factor in treatment decisions but is poorly understood in older adults with lower gastrointestinal (GI) malignancies. Our objective was to compare acute adverse events (AAEs) of older and younger adults with lower GI malignancies treated on NRG studies.&lt;h4>Methods&lt;/h4>Data from 6 NRG trials, testing combined modality therapy in patients with anal or rectal cancer, were used to test the hypothesis that older age was associated with increased AAEs. AAEs and compliance with protocol-directed therapy were compared between patients aged ≥70 and &lt; 70. Categorical variables were compared across age groups using the chi-square test. The association of age on AAEs was evaluated using a covariate-adjusted logistic regression</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-22T11:49:27.963Z</modification><creation>2025-04-06T00:07:15.096Z</creation></dates><accession>S-EPMC8967782</accession><cross_references><pubmed>34756496</pubmed><doi>10.1016/j.jgo.2021.10.008</doi></cross_references></HashMap>